They definitely did their best to discredit it. It's off patent, they have no financial incentive to promote it and huge incentive to burry it. They stand to m

They definitely did their best to discredit it. It's off patent, they have no financial incentive to promote it and huge incentive to burry it. They stand to make a lot of money off of their newer competitor to ivermectin called molnupiravir, just approved under emergency use authorisation.$700 per dose if I remember correctly vs less than a penny per dose to manufacture ivermectin.